Spectrum Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
62,134.00
45,719.00
50,785.00
69,770.00
91,248.00
120,011
Depreciation, Depletion & Amortization
22,096.00
25,352.00
31,869.00
26,492.00
27,972.00
28,409
Other Funds
7,000.00
-
-
5,030.00
27,189.00
7,266
Funds from Operations
9,631.00
10,732.00
5,617.00
22,663.00
52,224.00
84,305
Changes in Working Capital
7,545.00
14,359.00
1,127.00
17,796.00
13,369.00
21,902
Net Operating Cash Flow
2,086.00
3,627.00
6,744.00
40,459.00
38,855.00
62,403
Capital Expenditures
3,161.00
934.00
223.00
78.00
465.00
Purchase/Sale of Investments
-
4,093.00
3,061.00
-
15.00
Net Investing Cash Flow
14,330.00
21,841.00
2,838.00
679.00
1,081.00
Cash Dividends Paid - Total
-
-
-
6.00
-
Issuance/Reduction of Debt, Net
27,347.00
-
-
8,663.00
5,482.00
Net Financing Cash Flow
35,258.00
812.00
1,471.00
59,644.00
108,721.00
Net Change in Cash
16,607.00
26,364.00
9,799.00
18,481.00
69,101.00
Free Cash Flow
2,247.00
4,561.00
6,521.00
40,537.00
39,320.00
Deferred Taxes & Investment Tax Credit
33,252.00
1,122.00
210.00
104.00
5,237.00
31
Net Assets from Acquisitions
11,169.00
-
-
-
-
Change in Capital Stock
911.00
812.00
1,471.00
73,343.00
130,428.00
Exchange Rate Effect
2,235.00
1,708.00
1,254.00
25.00
316.00
Other Uses
-
25,000.00
-
601.00
601.00
About Spectrum Pharmaceuticals
View Profile
